Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

7.96
Delayed Data
As of 3:59pm ET
 -0.13 / -1.61%
Today’s Change
3.70
Today|||52-Week Range
9.25
+39.16%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close8.09
Today’s open8.10
Day’s range7.80 - 8.20
Volume23,769
Average volume (3 months)73,472
Market cap$186.5M
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book3.81

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...+0.12+2.65%
VTLVital Therapies Inc-0.15-2.51%
ITEKInotek Pharmaceutica...-0.05-0.73%
RDHLRedhill Biopharma Lt...-0.03-0.21%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs